CCI Photonics
Products
Learn more about the current problem and how our products provide a solution.
The Current Problem.
Microorganisms resistance to antibiotics also known as antimicrobial resistance (AMR) is a grave global health issue, directly causing 1.27 million deaths in 2019 and contributing to 4.95 million. In 2022 GLASS report indicated alarming resistance rates in 76 countries, notably in bacteria named Escherichia coli and Staphylococcus aureus.
Key bacterial pathogens like Klebsiella pneumoniae and Escherichia coli are leading causes of AMR-related deaths.
AMR is becoming a bigger problem each year in the United Kingdom, as shown by recent data from the UK Health Security Agency (UKHSA). In 2021, England recorded a significant increase of 2.2% in severe AMR infections, with the numbers rising from 52,842 to 53,985 cases, breaking down to a daily average of 148 hard-to-treat infections. The human cost of these superbugs is stark, with an estimated 12,000 individuals succumbing to such infections annually within the UK, and these numbers continue to climb.
As observed in Morecambe Bay Trust and on the literature, current methods for identifying AMR can take ~72 hours, as they rely on bacteria cultures, biochemical assays, and other analytical techniques like genetical identification.
Our Proucts & Solution.
The solution we propose to the overwhelming increase in AMR incidence lies on:
Our β-Prototype which is a portable diagnostic medical device, presents a transformative approach to diagnosing AMR, directly addressing a critical health-care need by drastically reducing the time that it takes to identify pathogens responsible for AMR. With the deployment of our device, healthcare providers can detect AMR in in-vitro and biofluid samples with over 90% accuracy in as little as 15 minutes.
For further information on our Unique biological-spectral database and AI-driven models, please get in touch.
Get in Touch
If you would like to learn more about our project, please complete our contact form to get in touch with the CCI Photonics team.